FISHERS, Ind. (Feb. 9, 2023) – Today, Animal Health’s most advanced microbiome company, BiomEdit, announced the appointment of its first full Board of Directors, led by longtime Animal Health executive leader, Patrick James, as Chairman. The board is comprised of five senior executive leaders with a diverse mix of experiences across Animal Health, Human Health and Financial sectors, as well as previous board and governance experience.
“We are delighted such a distinguished group of insightful leaders have agreed to help us shepherd in the next era of microbiome innovation as members of the BiomEdit Board of Directors,” said Aaron Schacht, president and CEO of BiomEdit, also serving as a board member.
Pat James, former chairman and CEO of Micronutrients at The Heritage Group, former president of Elanco Animal Health and a former executive at Eli Lilly and Company, leads the BiomEdit Board of Directors as Chairman. “The BiomEdit scientists are on the leading edge of breakthrough microbiome science using a unique platform to innovate novel products to revolutionize Animal Health and Nutrition,” said James.
Joining James and Schacht on the BiomEdit Board of Directors are Barbara Bodem (board member, Enovis and Syneos Health, former CFO of Hillrom), Paul Casady (consultant, Brakke Consulting; former executive leadership at Merial and Intervet/Schering-Plough), and Brett Wong (Principal at Anterra Capital).
Today’s announcement marks another milestone for the new company, following the November 2022 research collaboration with Atarraya to increase the sustainability of shrimp farming, the company’s 2022 Best Start-up in Animal Health award from S&P Global Animal Health, and its long-term strategic research and commercial partnership with Nutreco announced earlier that same month.
